| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1049460213 |
| P356 | DOI | 10.1023/A:1008882113177 |
| P698 | PubMed publication ID | 10767109 |
| P2093 | author name string | Perry GJ | |
| Brown SL | |||
| Booyse FM | |||
| Go RC | |||
| Kirk KA | |||
| Li XN | |||
| McGiffin DC | |||
| Holman WL | |||
| Benza RL | |||
| Hanson KA | |||
| Reeder VC | |||
| Grenett H | |||
| P2860 | cites work | Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease | Q34117320 |
| Plasminogen activator inhibitor type 1 gene is located at region q21.3-q22 of chromosome 7 and genetically linked with cystic fibrosis | Q34372572 | ||
| Plasminogen activator inhibitor in the blood of patients with coronary artery disease | Q34490676 | ||
| Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction | Q34545496 | ||
| Hypercoagulability and Reduced Fibrinolysis in Hyperlipidemia: Relationship to the Metabolic Cardiovascular Syndrome | Q35167577 | ||
| Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries | Q37131350 | ||
| The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. | Q38319093 | ||
| Clustering of cardiovascular risk factors: Targeting high-risk individuals | Q40440943 | ||
| The fibrinolysis and coagulation systems in ischaemic heart disease. Risk markers and their relation to metabolic dysfunction of the arterial intima. | Q40773106 | ||
| Prospective study of endogenous tissue plasminogen activator and risk of stroke | Q41036094 | ||
| Endogenous tissue-type plasminogen activator and risk of myocardial infarction | Q41079493 | ||
| Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up | Q41157353 | ||
| The human tissue plasminogen activator gene. | Q48364916 | ||
| Effects of metformin and metoprolol CR on hormones and fibrinolytic variables during a hyperinsulinemic, euglycemic clamp in man. | Q51595190 | ||
| Plasminogen activator inhibitor-1 (PAI-1) promoter polymorphism and coronary artery disease in non-insulin-dependent diabetes. | Q52870202 | ||
| Plasminogen activator inhibitor-1 expression in human liver and healthy or atherosclerotic vessel walls. | Q54200402 | ||
| Hypertriglyceridemia and regulation of fibrinolytic activity | Q57398969 | ||
| Quantification of Plasminogen Activators and Their Inhibitors in the Aortic Vessel Wall in Relation to the Presence and Severity of Atherosclerotic Disease | Q60652076 | ||
| A depression of active tissue plasminogen activator in plasma characterizes patients with unstable angina pectoris who develop myocardial infarction | Q67295801 | ||
| Tissue plasminogen activator and other risk factors as predictors of cardiovascular events in patients with severe angina pectoris | Q67989768 | ||
| Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity | Q68290719 | ||
| Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus | Q69018082 | ||
| Evidence for increased levels of plasminogen activator inhibitor and tissue plasminogen activator in plasma of patients with angiographically verified coronary artery disease | Q69187061 | ||
| Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction | Q69901572 | ||
| Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: correlation with age and serum triglyceride concentrations | Q70322551 | ||
| ECAT angina pectoris study: baseline associations of haemostatic factors with extent of coronary arteriosclerosis and other coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiography | Q70558786 | ||
| The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study. Etude CasTemoins de I'nfarctu | Q70924421 | ||
| Modulation of bovine microvascular endothelial cell proteolytic properties by inhibitors of angiogenesis | Q71656705 | ||
| Hypofibrinolysis and the insulin resistance syndrome | Q71721607 | ||
| Retinoic acid effects on endothelial cell function: interaction with interleukin 1 | Q72035091 | ||
| Insulin and PAI-1 levels during oral glucose tolerance test in patients with coronary heart disease | Q72072948 | ||
| Localization and production of plasminogen activator inhibitor-1 in human healthy and atherosclerotic arteries | Q72085509 | ||
| Potentiation by hypercholesterolemia of the induction of aortic intramural synthesis of plasminogen activator inhibitor type 1 by endothelial injury | Q72094659 | ||
| Regulation of baboon arterial smooth muscle cell plasminogen activators by heparin and growth factors | Q72121578 | ||
| Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study | Q72235431 | ||
| Abnormal expression of plasminogen activators in aortic aneurysmal and occlusive disease | Q72390494 | ||
| Hemostatic function and coronary artery disease | Q72519882 | ||
| Plasminogen activator inhibitor 1 and atherothrombosis | Q72595137 | ||
| The insulin resistance syndrome in smokers is related to smoking habits | Q72858524 | ||
| Interrelationships between plasma levels of plasminogen activator inhibitor, tissue plasminogen activator, lipoprotein (a), and established cardiovascular risk factors in a north Swedish population | Q93530701 | ||
| P433 | issue | 2 | |
| P921 | main subject | angiography | Q468414 |
| coronary artery disease | Q844935 | ||
| P304 | page(s) | 143-150 | |
| P577 | publication date | 1998-05-01 | |
| P1433 | published in | Journal of Thrombosis and Thrombolysis | Q15766541 |
| P1476 | title | Gene Polymorphisms for PAI-1 Are Associated with the Angiographic Extent of Coronary Artery Disease | |
| P478 | volume | 5 |
| Q73218081 | Lack of association of a common polymorphism of the plasminogen activator inhibitor-1 gene with coronary artery disease and myocardial infarction |
| Q34384926 | Plasminogen activator inhibitor type-1 (part one): basic mechanisms, regulation, and role for thromboembolic disease |
| Q34376916 | Plasminogen activator inhibitor type-1 in cardiovascular disease. Status report 2001. |
| Q51802957 | Plasminogen activator inhibitor-1 C/G polymorphism in relation to plasma levels in rheumatoid arthritis. |
| Q64944600 | Plasminogen activator inhibitor-1 polymorphisms as a risk factor for chronic periodontitis in North Indian population. |
| Q34212957 | Relationship of metabolic syndrome and its components with -844 G/A and HindIII C/G PAI-1 gene polymorphisms in Mexican children. |
| Q35160972 | Serum level of plasminogen activator inhibitor type-1 in addicted patients with coronary artery disease |
| Q33962018 | The impact of molecular medicine upon early cardiovascular drug development |
Search more.